Crowdonomics
All companies
ABBY BY GOGOTECH INC. logo

ABBY BY GOGOTECH INC.

Operating

ABBY by GOGOTECH Inc.

Software & AI · B2C · Wilmington, DE · Founded 2021

Safe, advanced, affordable, personal mobility

Post-money valuation ⓘ
$6.1M
As of Oct 2024 · from Reg CF Offering (2024) · pre-money + amount raised, not a traded price
Total raised
$300,011
Across 2 rounds since 2022
Latest share price
$0.52
Reg CF · Common Stock · Oct 2024 offering price

Financials

FY2020–FY2023 · from SEC filings · hover any figure for its source
$0
2020
$0
−$97K
2021
$0
−$307K
2022
$0
−$201K
2023
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020 unaudited
FY2021 unaudited
FY2022 reviewed
FY2023 reviewed
Income statement
Revenue
$0
$0
$0
$0
Cost of goods sold
$0
$0
$0
$0
Net income
$0
-$97,224
-$307,342
-$200,568
Taxes paid
$0
$0
$0
$0
Balance sheet
Cash
$0
$110,447
$1,126
$7,117
Accounts receivable
$0
$0
$0
$0
Total assets
$0
$110,447
$153,285
$157,696
Short-term debt
$0
$120,671
$0
$0
Long-term debt
$0
$0
$413,403
$618,383
Total liabilities
$0
$120,671
$413,403
$618,383
Other
Headcount
—
4
—
2

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$10.0M
Valuation cap
$6.0M
pre-money
Reg CF · SAFE · Sep 2022
Reg CF · Common · Oct 2024

Blue bars are the pre-money valuation the company stated for a priced round. Dashed amber bars are a SAFE or convertible note's valuation cap — the most it converts at, not what the company is worth, so don't compare them with the other bars.

Fundraising history

Raised $53.6K / $618KInvestors 94Post-money $6.1M
Reg CF · SAFE · Sep 2022Closedvia WeFunder
Raised $246.4K / $1.1MInvestors 119Valuation cap $10M

Team

4 people
Dr. Clarence Tan
Co-Founder and Advisor

Dr. Clarence Tan, is a futurist, academic and angel investor. Clarence is a Global Ambassador/Board Advisor at OpenExO and was formerly APAC Ambassador for Singularity University. Adjunct Professor at Bond University & Griffith University, Founder, Bond Wireless, CEO, Austanco Pty Ltd, P.E. and founding member, Gold Coast Angel Investors Group & Founder EPIChub.org, revenue-based investment platform.

John DeBenedette
Founder, CEO, Director, Officer, Executive, Principal Securities Holder, and Principal Financial Officer

John is an experienced founder and a wheelchair user on/off himself since a 1985 accident. Prior to ABBY he was CTO then Chief Commercial Officer at INTTRA.com, a container shipping SaaS platform (acquired by E2Open in 2018). ABBY is his third startup and the 2nd aiming to disrupt a huge but deeply flawed industry. John leads a lean but uniquely qualified team that's mission driven to democratize powered mobility, addressing the massive global unmet need for safe, advanced & affordable assistive mobility technology.

Wei Wen Jing
Engineer

Wei has over 20 years designing and manufacturing battery electric vehicles. Wei manages our supply chain, production & quality control processes in our Shenzhen operation.

Dr. Brent Staton
Advisor

Dr. Brent Staton is a Practicing Medical Doctor and Chief Executive Officer and Chief Financial Officer with management of Chief Medical Officers for an Accountable Care Organization. Skilled in Population Health Management, Value Based Care Delivery and Contract Negotiations, Data Analytics, Family Medicine, Administrative Medicine, Healthcare Management, Healthcare, Leadership, and Population Health. Strong business development professional graduated from University of Tennessee-Health Science Center College of Medicine, Flinders University of South Australia School of Medicine, Life University and Tennessee Technological University College of Business.

Names and titles as disclosed on StartEngine, SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not requiredFewer than 300 holders of record

Filed 1 of 4 annual reports (FY2022–FY2025)

119 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-UJan 15, 20250001665160-25-000065
    EDGAR
  • Form COct 9, 20240001665160-24-001389
    EDGAR
  • Form C-ARJun 24, 20240001670254-24-000724
    EDGAR
  • Form C/AJan 25, 20230001670254-23-000048
    EDGAR
  • Form CAug 26, 20220001670254-22-000879
    EDGAR
Source: ManualCIK 0001942319DEShare price $0.52

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.